Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma. - Domenger A; Ricci D; Mayau V; Majlessi L; Marcireau C; Dadaglio G; Demangel C (Frontiers in oncology, 2023)